4.6 Article

Optimized Approaches for Generation of Integration-free iPSCs from Human Urine-Derived Cells with Small Molecules and Autologous Feeder

Journal

STEM CELL REPORTS
Volume 6, Issue 5, Pages 717-728

Publisher

CELL PRESS
DOI: 10.1016/j.stemcr.2016.04.001

Keywords

-

Funding

  1. National Basic Research Program of China [2012CB966503, 2015CB964901, 2015CB964902]
  2. Cooperation Grant of the Natural Science Foundation of Guangdong Province [2014A030312012]
  3. Frontier and Key Technology Innovation special grant from Department of Science and Technology of Guangdong province [2014B020225006, 201508020258]
  4. International Science & Technology Cooperation Program of China [2014DFA30180]
  5. National Natural Science Foundation of China [31371514, 81372249, 81300431]
  6. Science and Information Technology of Guangzhou Key Project [201508020258]
  7. Hundred Talents Program'' of the Chinese Academy of Science
  8. Science and Technology Planning Project of Guangdong Province, China [2013B091500072]
  9. Project of Department of Education of Guangdong Province, China [2014GKXM029]
  10. Science and Technology Project of Guangzhou [2014J4100129, 2015A020212023]

Ask authors/readers for more resources

Generation of induced pluripotent stem cells (iPSCs) from human urine-derived cells (hUCs) provides a convenient and non-invasive way to obtain patient-specific iPSCs. However, many isolated hUCs exhibit very poor proliferation and are difficult to reprogram. In this study, we optimized reprogramming approaches for hUCs with very poor proliferation. We report here that a compound cocktail containing cyclic pifithrin-a (a P53 inhibitor), A-83-01, CHIR99021, thiazovivin, NaB, and PD0325901 significantly improves the reprogramming efficiency (170-fold more) for hUCs. In addition, we showed that replacement of Matrigel with autologous hUC feeders can overcome the reprogramming failure due to the massive cell death that occurs during delivery of reprogramming factors. In summary, we describe improved approaches to enable iPSC generation from hUCs that were otherwise difficult to reprogram, a valuable asset for banking patient-specific iPSCs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available